![Richard Christopher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Christopher
Directeur Général chez
LEXARIA BIOSCIENCE CORP.
Fortune : 39 130 $ au 31/05/2026
Profil
Mr. Richard C.
Christopher is a Chief Executive Officer & Director at Lexaria Bioscience Corp.
He is on the Board of Directors at Lexaria Bioscience Corp.
Mr. Christopher was previously employed as a Chief Financial Officer & Treasurer by Invivo Therapeutics Holdings Corp., a CFO, Secretary, Treasurer & Executive VP by iCAD, Inc., a Chief Operating & Financial Officer by Lucid, Inc., a Chief Financial Officer & Vice President-Finance by DUSA Pharmaceuticals, Inc., and a Manager-North American Cost Accounting by W.
R.
Grace & Co.-Conn.
He received his undergraduate degree from Bentley University and a graduate degree from Suffolk University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LEXARIA BIOSCIENCE CORP. 0,26 % | 01/12/2025 | 65 000 ( 0,26 % ) | 39 130 $ | 31/05/2026 |
Postes actifs de Richard Christopher
| Sociétés | Poste | Début |
|---|---|---|
| LEXARIA BIOSCIENCE CORP. | Directeur Général | 31/08/2024 |
Anciens postes connus de Richard Christopher
| Sociétés | Poste | Fin |
|---|---|---|
| INVIVO THERAPEUTICS HOLDINGS CORP. | Directeur Financier/CFO | 01/01/2024 |
| ICAD | Directeur Financier/CFO | 11/01/2019 |
| CALIBER IMAGING & DIAGNOSTICS, INC. | Directeur Financier/CFO | 01/12/2016 |
DUSA Pharmaceuticals, Inc.
 DUSA Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets photodynamic therapies & dermatological pharmaceutical products | Directeur Financier/CFO | 01/04/2013 |
| W. R. GRACE & CO. | Comptroller/Controller/Auditor | 01/12/2000 |
Formation de Richard Christopher
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
37
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
DUSA Pharmaceuticals, Inc.
DUSA Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets photodynamic therapies & dermatological pharmaceutical products | Health Technology |
W. R. Grace & Co.-Conn.
 W. R. Grace & Co.-Conn. Chemicals: Major DiversifiedProcess Industries Manufactures and markets chemical catalysts, absorbents & synthetic silicas | Process Industries |
Lexaria Bioscience Corp.
 Lexaria Bioscience Corp. Pharmaceuticals: MajorHealth Technology Engages in drug delivery technology | Health Technology |
iCAD, Inc.
 iCAD, Inc. Packaged SoftwareTechnology Services Operates as an AI platform for cancer detection | Technology Services |
Caliber Imaging & Diagnostics, Inc.
 Caliber Imaging & Diagnostics, Inc. Medical SpecialtiesHealth Technology Manufactures noninvasive diagnostic confocal imagers | Health Technology |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Suffolk University
 Suffolk University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Invivo Therapeutics Holdings Corp.
 Invivo Therapeutics Holdings Corp. BiotechnologyHealth Technology Develops technologies for the treatment of spinal cord injuries | Health Technology |
